Medicine passport

Xeljanz 11 mg 11 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Tofacitinibcitraat
Strength
11 mg
Form
tablet met verlengde afgifte
ATC code
L04AF01
Registered in
Netherlands · Pfizer Europe MA EEIG
Prescription
Prescription only
RVG
EU/1/17/1178

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
XELJANZ11 mg · comprimido de liberación prolongadaPrescription onlyPfizer Europe Ma Eeig1171178012

Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Canada 2 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
TARO-TOFACITINIB XR11 mg · tablet (extended-release)Prescription onlyTaro Pharmaceuticals Inc02553988
XELJANZ XR11 mg · tablet (extended-release)Prescription onlyPfizer Canada Ulc02470608

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/xeljanz-11-mg-11-mg-tablet-met-verlengde-afgifte